Avalyn Pharma Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -110 | |||
EBITDA | -31,180 | -26,708 | -20,182 | -17,493 |
EBIT | -31,290 | -26,771 | -20,191 | -17,503 |
Net Income | -28,935 | -26,869 | -20,191 | -17,503 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,345 | -30,209 | -20,697 | -19,283 |
Cash | 264,197 | 92,310 | ||
Basic Shares | 44,333 | 41,812 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -91,250 | -57,092 |
EBIT | -91,292 | -57,121 |
Net Income | -85,204 | -49,744 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -81,828 | -48,463 |
Cash | 52,315 | 23,955 |
Basic Shares | 41,812 | 41,812 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.98 |
2026-03-31 | -$21.83 |